CYTOTOXIC T-LYMPHOCYTE IMMUNOTHERAPY FOR OVARIAN CANCER: A PILOT STUDY

The objective was to evaluate the toxicity and feasibility of intraperitoneal (IP) infusion of tumor-specific cytotoxic T-lymphocytes (CTL) as therapy for recurrent ovarian cancer, and to determine if repetitive cycles of CTL generation and infusion measurably increases the host’s ovarian cancer imm...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wright, Stephen E., Rewers-Felkins, Kathleen A., Quinlin, Imelda S., Phillips, Catherine A., Townsend, Mary, Philip, Ramila, Dobrzanski, Mark J., Lockwood-Cooke, Pamela R., Robinson, William
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276404/
https://ncbi.nlm.nih.gov/pubmed/22306908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e318243f213
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires